Yizhen Guo

机构：The Ohio State University · ORCID：0009-0002-2994-127X

发表论文 45 篇 · 总被引 1022 次 · h-index 16

代表论文

• Novel ginsenoside-based multifunctional liposomal delivery system for combination therapy of gastric cancer (2019 · Theranostics · 被引 169)
• One Stone Four Birds: A Novel Liposomal Delivery System Multi-functionalized with Ginsenoside Rh2 for Tumor Targeting Therapy (2020 · Nano-Micro Letters · 被引 109)
• Serum Albumin: Early Prognostic Marker of Benefit for Immune Checkpoint Inhibitor Monotherapy But Not Chemoimmunotherapy (2022 · Clinical Lung Cancer · 被引 45)
• Combined inhibition of pyruvate dehydrogenase kinase 1 and lactate dehydrogenase a induces metabolic and signaling reprogramming and enhances lung adenocarcinoma cell killing (2023 · Cancer Letters · 被引 39)
• Targeting glucose metabolism to develop anticancer treatments and therapeutic patents (2022 · Expert Opinion on Therapeutic Patents · 被引 39)
• Epigallocatechin gallate circumvents drug‐induced resistance in non‐small‐cell lung cancer by modulating glucose metabolism and AMPK/AKT/MAPK axis (2023 · Phytotherapy Research · 被引 30)